Patent ID: 11919966
Assignee: ABLYNX N.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 5:
6. The method according to claim 1, wherein said at least one immunoglobulin single variable domain essentially consists of a dAb, an immunoglobulin that is suitable for use as a dAb, a VHH sequence, a humanized VHH sequence, a camelized VH sequence, or a VHH sequence that has been obtained by affinity maturation; and wherein said at least one immunoglobulin single variable domain is chosen from the group consisting of ISVDs with SEQ ID NOs: 1-71 and 268-275 and ISVDs that have a sequence identity of more than 80% with SEQ ID NOs: 1-71 and 268-275.